Meros Equity
+420234290897
Personal Account
Century Therapeutics
IPO IPSC.NASDAQ Past

Century Therapeutics

developer of allogeneic living drugs created to offer treatment for cancer

Company website
Ticker

IPSC.NASDAQ

Market

us

Foundation year

2018

Close date

9/1/2021

IPO date

6/17/2021

Placement price

$20

Profitability

34%

About

Total Funding 

$560M

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.

Number of employees

100-150

Headquarters

Philadelphia, Pennsylvania, United States

Meros Equity
+420234290897
info@meros-equity.com

2026 © All rights reserved

You can always come to our office to discuss any questions with our manager

Sharjah

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Bílkova 855/19, 110 00 Praha 1

Bílkova 855/19, 110 00 Praha 1

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.